30-MAY-2023 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S2012-Small Cell NEC, Stg IV, Combo Chemo +/- Atezo 1 Y 1 Platinum/Etoposide + Atezo Induction + Maintenance 189 3 3 1 1 0 0 06/28/2022 162 56
        2 Platinum/Etoposide + Atezo Induction   5 5 5 3 0 0      
        3 Platinum/Etoposide Only   4 4 3 1 1 0      
            12 12 9 5 1 0      
 
Yes A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   42 2 0 0 0 0 02/22/2016 261 92
            42 2 0 0 0 0      
 
    1 E Total Registrations   8 1 0 0 0 0 02/22/2016    
            8 1 0 0 0 0      
 
No AGCT1531-Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 1 E Total Registrations   1 0 0 0 0 0 10/07/2021 207 112
            1 0 0 0 0 0      
 

30-MAY-2023 6:10

ERLYTX Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs
# of
CURR
IRBs
AGCT1531 Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 2 Late Randomization Callback 08-May-17 207 112